Nanobiotix (NBTX) Retained Earnings (2019 - 2025)

Nanobiotix's Retained Earnings history runs 7 years deep, the most recent figure standing at -$27.9 million for Q4 2025.

• On a quarterly basis, Retained Earnings rose 61.69% year-over-year to -$27.9 million in Q4 2025; TTM through Dec 2025 was -$27.9 million, a 61.69% increase from a year earlier, with the FY2025 full-year figure at -$27.1 million, up 62.82% from the prior year.
• Retained Earnings retreated to -$27.9 million in Q4 2025 per NBTX's latest filing, from $776524.3 in the prior quarter.
• Across five years, Retained Earnings topped out at $792589.3 in Q2 2024 and bottomed at -$72.8 million in Q4 2024.
• The 5-year median for Retained Earnings is -$13.6 million (2021), against an average of -$25.2 million.
• Across the five-year window, Retained Earnings soared 70.54% in 2021 and tumbled 70.45% in 2024, its largest moves.
• Year by year, Retained Earnings stood at -$53.8 million in 2021, then fell by 8.23% to -$58.2 million in 2022, then climbed by 26.6% to -$42.7 million in 2023, then tumbled by 70.45% to -$72.8 million in 2024, then jumped by 61.69% to -$27.9 million in 2025.
• Per Business Quant, the three latest NBTX Retained Earnings figures stand at -$27.9 million (Q4 2025), $776524.3 (Q2 2025), and -$72.8 million (Q4 2024).